Containing dexmedetomidine, etomidate, midazolam, propofol or their salts
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: > Other: > Other > Other: > Medicaments primarily affecting the central nervous system: > Anticonvulsants, hypnotics and sedatives: > Containing dexmedetomidine, etomidate, midazolam, propofol or their salts
Duty Rate (from China)
Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Products classified under HTS 3004.90.92.37
Dexmedetomidine Hydrochloride Injection 100mcg/mL
This sterile injectable solution of dexmedetomidine hydrochloride is used for sedation in ICU patients during mechanical ventilation. It falls under HTS 3004.90.92.37 as a mixed product put up in measured doses containing dexmedetomidine salt for therapeutic use primarily affecting the central nervous system as a sedative. Supplied in 2mL single-dose vials for retail sale to hospitals.
Midazolam Hydrochloride Syrup 2mg/mL
Pediatric oral syrup formulation of midazolam hydrochloride for pre-procedure sedation in children. Classified under HTS 3004.90.92.37 due to its midazolam salt content, put up in measured doses for therapeutic hypnotic/sedative use affecting the CNS. Bottled in 118mL for retail pharmacy sale.
Propofol Injectable Emulsion 10mg/mL
Lipid emulsion of propofol for intravenous induction and maintenance of general anesthesia during surgery. This product is under HTS 3004.90.92.37 as it contains propofol in a mixed formulation, measured doses in 20mL vials for retail medical use as a CNS sedative-hypnotic.
Etomidate Injection 2mg/mL
Clear aqueous solution of etomidate for rapid IV induction of anesthesia in hemodynamically unstable patients. Falls under HTS 3004.90.92.37 for containing etomidate in measured 10mL ampules designed for retail therapeutic use as a CNS hypnotic sedative.
Dexmedetomidine Prefilled Syringe 4mcg/mL
Ready-to-use prefilled glass syringe containing dexmedetomidine hydrochloride for procedural sedation. Classified in HTS 3004.90.92.37 as a sedative in measured dose transdermal-style administration system for CNS therapeutic effects, packaged for retail hospital use.
Midazolam Nasal Spray 5mg/spray
Intranasal spray delivery of midazolam for acute seizure termination in pediatric patients. This falls under HTS 3004.90.92.37 as it contains midazolam in measured doses for retail sale, functioning as a CNS sedative anticonvulsant.
Propofol 1% IV Infusion Bag
Large volume 100mL flexible infusion bag of propofol emulsion for prolonged surgical sedation. Under HTS 3004.90.92.37 for propofol content in measured retail doses as a CNS hypnotic for therapeutic anesthesia maintenance.
Etomidate Liposomal Injection
Advanced liposomal formulation of etomidate reducing injection site pain, in 20mL vials. Classified HTS 3004.90.92.37 as mixed product containing etomidate for measured sedative-hypnotic CNS therapy.
Midazolam HCl 5mg/mL Carpuject
Carpuject system with midazolam hydrochloride for rapid emergency sedation in prehospital settings. HTS 3004.90.92.37 applies for this measured dose CNS sedative containing midazolam salt for retail sale.
Dexmedetomidine 200mcg/2mL Vial
Concentrated dexmedetomidine injection vial for dilution prior to ICU infusion sedation. Under HTS 3004.90.92.37 as measured dose sedative with dexmedetomidine salt for CNS therapeutic retail use.